Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
JHS Svendgaard Laboratories Limited (NSE: JHS), ISIN INE544H01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JHS last traded at ₹8.36 (+1.83%), with a 52-week range of ₹6.15 to ₹13.83 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 33.85%, FIIs 3.14%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.